The variety of endovascular devices and techniques to treat occlusive disease has exploded over the past 10 years and critical evaluation of the reported results may be problematic. The Society for Vascular Surgery has released new reporting standards focused on endovascular treatment of chronic lower extremity peripheral artery disease. Recommended reporting standards for lower extremity ischemia were last published by the SVS in 1997.
This year’s Lifetime Achievement Award winner gets called a lot of things by his many nominators: quadruple hitter, visionary, mentor, revolutionary, unsurpassed, profoundly effective.
The unique relationship that vascular surgeons enjoy with their patients has enabled our specialty to have a special claim on the way we care for patients. Outgoing SVS President Bruce Perler spoke during the 2016 Vascular Annual Meeting near Washington, D.C. on June 10.
A groundbreaking trial needs more patients enrolled – quickly – and the SVS is asking for your help.
CHICAGO, Illinois - Conventional wisdom might suppose that everyone would avoid surgery if possible.
CHICAGO, Illinois, May 6, 2016 –The Society for Vascular Surgery Board of Directors is pleased to announce Kenneth M. Slaw, Ph.D., as the society’s next executive director, replacing Rebecca Maron, CAE, who will retire May 30, 2016.
The Society for Vascular Surgery and the SVS Foundation present a number of awards during the Vascular Annual Meeting. The achievements and special efforts of many also receive special recognition.
Chicago, Illinois– Could microbes in the gut impact human arteries? Surprising early research suggests they might play a role.
While the 2016 Vascular Annual Meeting includes postgraduate courses, hands-on workshops and other courses, it also features special lectures and forums that add to attendees' overall understanding of the treatment of vascular diseases. Special VAM events include:
CHICAGO, Illinois - Previous studies have shown that women are more likely than men to die after vascular surgery, but a new study shows that they are far more likely to be readmitted to the hospital after aortic aneurysm surgery as well.
A letter to members from SVS President Dr. Bruce A. Perler and SVS PAC Steering Committee Chair Dr. Randall DeMartino:
A recent review of patients who had undergone carotid, lower extremity bypass, or abdominal aortic aneurysm surgeries found that patients who received both statins and antiplatelet medications were far more likely to be alive five years later. Patients placed on both an antiplatelet agent and cholesterol medication had an adjusted 40 percent reduced risk of death at five years compared to those who received neither drug. Being on either one of these medications was also important, and was associated with an adjusted 30 percent reduced risk of death compared to those on neither medication. When considered differently, an extra 14 of every 100 patients were alive at five years if on both medications.
The variety of endovascular devices and techniques to treat occlusive disease has exploded over the past 10 years and critical evaluation of the reported results may be problematic. The Society for Vascular Surgery has released new reporting standards focused on endovascular treatment of chronic lower extremity peripheral artery disease. Recommended reporting standards for lower extremity ischemia were last published by the SVS in 1997.
This year’s Lifetime Achievement Award winner gets called a lot of things by his many nominators: quadruple hitter, visionary, mentor, revolutionary, unsurpassed, profoundly effective.
The unique relationship that vascular surgeons enjoy with their patients has enabled our specialty to have a special claim on the way we care for patients. Outgoing SVS President Bruce Perler spoke during the 2016 Vascular Annual Meeting near Washington, D.C. on June 10.
A groundbreaking trial needs more patients enrolled – quickly – and the SVS is asking for your help.
CHICAGO, Illinois - Conventional wisdom might suppose that everyone would avoid surgery if possible.
CHICAGO, Illinois, May 6, 2016 –The Society for Vascular Surgery Board of Directors is pleased to announce Kenneth M. Slaw, Ph.D., as the society’s next executive director, replacing Rebecca Maron, CAE, who will retire May 30, 2016.
The Society for Vascular Surgery and the SVS Foundation present a number of awards during the Vascular Annual Meeting. The achievements and special efforts of many also receive special recognition.
Chicago, Illinois– Could microbes in the gut impact human arteries? Surprising early research suggests they might play a role.
While the 2016 Vascular Annual Meeting includes postgraduate courses, hands-on workshops and other courses, it also features special lectures and forums that add to attendees' overall understanding of the treatment of vascular diseases. Special VAM events include:
CHICAGO, Illinois - Previous studies have shown that women are more likely than men to die after vascular surgery, but a new study shows that they are far more likely to be readmitted to the hospital after aortic aneurysm surgery as well.
A letter to members from SVS President Dr. Bruce A. Perler and SVS PAC Steering Committee Chair Dr. Randall DeMartino:
A recent review of patients who had undergone carotid, lower extremity bypass, or abdominal aortic aneurysm surgeries found that patients who received both statins and antiplatelet medications were far more likely to be alive five years later. Patients placed on both an antiplatelet agent and cholesterol medication had an adjusted 40 percent reduced risk of death at five years compared to those who received neither drug. Being on either one of these medications was also important, and was associated with an adjusted 30 percent reduced risk of death compared to those on neither medication. When considered differently, an extra 14 of every 100 patients were alive at five years if on both medications.